Dabarar gwadawa ce ta gaskiya tare da sakamako mai tasiri da ban tsoro. Big Pharma da sauran abubuwan da ke da kuɗaɗen tallafi suna ɗaukar nauyin gwaje-gwajen likita na "marasa son zuciya" da nufin ɓata hanyoyin mafi rahusa. Yin watsi da kurakuran da ke cikin hanyar, kafofin watsa labaru suna gudana tare da labarin da ake so, wanda aka haɓaka ta hanyar ingantaccen ƙoƙarin hulɗar jama'a.
Kafofin watsa labarun suna rufe madadin ra'ayoyi da suka. Sakamakon ƙananan zaɓi ne da farashi mafi girma don alluran rigakafi da magungunan rigakafin cutar hoto - mummunan ga lafiyar mabukaci, amma yana da kyau ga layin kamfanonin harhada magunguna.
Wani sabon gwaji na asibiti da aka bayar da aka sani da "TARE"Wataƙila da nufin yin nazarin tasirin ivermectin don kula da Covid, ya nuna daidai matsalar. A ce gwajin yana da kurakurai da yawa ba a faɗi ba. Idan aka ba da wasu kaɗan, babu ƙayyadaddun ƙayyadaddun keɓancewa ga mahalarta gwaji akan ivermectin, ma'ana duka ƙungiyoyin gwaji sun sami damar yin amfani da magani iri ɗaya. yadu amfani.
An saita taga jiyya na kwanaki uku kacal, bayyanannen “bayyana” na rashin amfani da allurai da aka bayar, misali, cewa duka Merck's molnupiravir da Pfizer'Paxlovid suna buƙatar kwanaki biyar. A zahiri an fara gwada gwajin kashi ɗaya ne kawai, mai yiwuwa har sai masu binciken sun fahimci ba za su taɓa musanta wani abu ba tare da wannan tsarin.
Kuma an gudanar da gwajin ne a lokacin da ake fama da babban bambance-bambancen gamma, daya daga cikin bambance-bambancen na Covid. Adadin gwajin ya yi ƙasa sosai fiye da yadda likitocin Brazil na yau da kullun ke ba marasa lafiya magani a lokacin don dacewa da ƙarfin nau'in.
Duk da wadannan da sauran kura-kurai da aka bayyana a fili, manyan kafafen yada labaran kasar sun yi ta yada sakamakon. "Ivermectin Bai Rage Asibitin Covid-19 ba a cikin Gwaji mafi Girma har zuwa yau" Wall Street Journal, yayin da a New York Times Babban labarin da aka ba da sanarwar, "Ivermectin Baya Rage Hadarin Asibitin Covid, Babban Binciken Bincike."
Manyan shafukan sada zumunta sun dauki matakai masu tsauri don murkushe tattaunawar da ta biyo baya da ke nuna kwarin guiwar tambayar layin kamfanin. Misali, danna kan a Reddit thread wanda ke nuna MDs, PhDs da ƙwararrun kiwon lafiyar jama'a suna tattaunawa game da bazuwar gwajin TOGETHER ya fara kawo masu amfani zuwa wani shafi mai ban tsoro tare da “keɓewa”, yana mai kira ga masu karatu su “da fatan za a tuntuɓi likitan ku.” Mafi girman ɓarna da ake iya tunanin ana iya samuwa ga kowane yaro akan Intanet, amma tattaunawa ta likitanci ta zo da alamar gargaɗi.
Sai dai kash, hargitsin bai tsaya nan ba. California tana turawa dokokin (Taron Majalisar 2098) don hukunta likitocin da suka kuskura su yi tambaya game da karatun bogi. Sakamakon da aka tsara yana da girma: asarar lasisin likita, rayuwar kowane likita. Idan aka yi nasara, sauran jihohi za su yi koyi. Wannan yana da matukar damuwa ga aikin likitanci.
Duk wani rashin jituwa da zai iya tasowa game da Covid, haɓaka samun magunguna tare da ingantaccen magani yakamata ya zama manufa ta duniya. Don ivermectin, irin wannan binciken wanda ya fi girma girma, wanda masu bincike suka gudanar ba tare da wani rikice-rikice na sha'awa ba, sun gano maganin ya haifar da raguwa mai yawa a cikin kamuwa da cutar Covid, asibiti da mace-mace-duk da haka kusan ba a sami labarin watsa labarai ba.
Haka kuma, mai rahusa kuma daidai gwargwado jiyya iri ɗaya kamar fluvoxamine, tare da manyan gwaje-gwajen da aka buga a cikin Lancet da JAMA suna nuna sakamako mai kyau akan Covid, sun kasa samun shawarwari daga hukumomi ko ƙungiyoyin likita.
Ƙare wannan sake zagayowar ɓarna na dindindin yana buƙatar sabunta tsarin amincewar mu marasa aiki. Dole ne a kafa kwamiti mai zaman kansa wanda ba shi da rigingimun masana'antar harhada magunguna don sa ido kan gwaje-gwajen magungunan da aka sake amfani da su. Ya kamata shawarwarin su kasance bisa gwaje-gwajen da ƙwararrun masana marasa son rai suka tsara da kuma sakamako na ainihi, ba wanda ake so ba, kuma masu tsara manufofi ko masu rubutawa waɗanda suka yi watsi da sakamakon binciken ya kamata a yi la'akari da su.
Dole ne kuma mu tunatar da masana kimiyya da hukumomin da ke kula da cewa bayanan gwaji na lura - inda aka kwatanta samfurin yawan mutanen da ke shan magani da waɗanda ba sa - daidai yake da inganci at manufofin sanarwa. Gwaje-gwajen da bazuwar bazuwar na iya samar da bayanai masu amfani, amma rikitarwarsu, farashi, da jinkirin jiyya suna haifar da kurakurai kuma da kyau rufe magungunan marasa tsada daga tsarin yarda, ba tare da la’akari da ingancinsu ba.
A matsayin wani ɓangare na ci gaba da taka-tsantsan game da Covid, lafiyar jama'a da zaɓaɓɓun jami'ai suna sha'awar cewa ba a yi cutar da mu ba. A kan haka, sun yi daidai. Tuni, sabbin bambance-bambancen Omicron suna ɗaukar hankalin kafofin watsa labarai tare da fara sabuwar muhawara kan matakan kiwon lafiyar jama'a. Philadelphia ya riga sake sanyawa abin rufe fuska kawai ya soke shi don mayar da martani ga koma bayan jama'a. Domin yaƙar sabbin nau'ikan, dole ne mu mai da hankalinmu mara son rai ga magungunan da aka sake yin su. Inganci, samuwa, da farashi ya kamata su zama ka'idodin jagora, ba layin ƙasa na manyan kamfanonin harhada magunguna ba.
-
Dokta Pierre Kory kwararre ne na Kulawa na Huhu da Mahimmanci, Malami/Mai bincike. Shi ne kuma Shugaban Emeritus na ƙungiyar masu zaman kansu Front Line COVID-19 Critical Care Alliance wanda manufarsa ita ce haɓaka mafi inganci, shaida/ka'idojin jiyya na COVID-19.
Duba dukkan posts
